Skip to content

Resection of large esophageal leiomyoma by a combined thoracoscopic-endoscopic submucosal tunneling method.

Resection of large esophageal leiomyoma by a combined thoracoscopic-endoscopic submucosal tunneling method.

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2500099668
Enrollment
Unknown
Registered
2025-03-27
Start date
2023-12-01
Completion date
Unknown
Last updated
2025-03-31

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

esophageal submucosal tumor

Interventions

Observation Group:None

Sponsors

The First Affiliated Hospital of Wenzhou Medical University
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1.Imaging (CT) and endoscopy, as well as endoscopic ultrasound, are used for the presumptive diagnosis of a large esophageal submucosal leiomyoma (larger than 4.0 cm). 2.Individuals presenting with symptoms of dysphagia or retrosternal discomfort; 3.Follow-up observation reveals progressive enlargement of the tumor, or irregular follow-up adherence, significant psychological stress, and patients with a strong desire for endoscopic treatment.

Exclusion criteria

Exclusion criteria: 1.Concomitant with severe cardiovascular, respiratory, hepatic, renal, cranial, hematopoietic system disorders, or psychiatric illnesses that preclude cooperation or tolerance of surgery; 2.patients with a fear of being unable to withstand surgical procedures.

Design outcomes

Primary

MeasureTime frame
Tumor size;

Countries

China

Contacts

Public ContactWu WenZhi

The First Affiliated Hospital of Wenzhou Medical University

wwzljy@163.com+86 577 5557 9193

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026